It is a pharma private limited company based in Kapashera, Delhi, India, established in 2006.
2006 | Kapashera, Delhi, India | ActiveRejuvendus Clinical Research Private Limited, a active private limited company, was established on 08 November 2006 in Kapashera, Delhi, India. Engaging in pharma contract r&d within the hospital and medical care sector, it holds CIN: U24232DL2006PTC155302. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Anupam Gaur (Director), Neera Sharma (Director), Vikas Shri Prakash (Director). Past directors included Prateek Gupta, Neera Sharma. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 31/55, 1St Floor Gali No. - 1, Kapashera, Delhi, 110037.
U24232DL2006PTC155302
155302
08 November 2006
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Rejuvendus Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anupam Gaur | Director | 08 Nov 2006 | Current |
| Neera Sharma | Director | 20 Jan 2010 | Current |
| Vikas Shri Prakash | Director | 08 Nov 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Feb 2007 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Rejuvendus Clinical Research Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 14.41% decrease in profit. The company's net worth dipped by a decrease of 0.95%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Rejuvendus Clinical Research had a promoter holding of 67.00% and a public holding of 33.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Rejuvendus Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Rejuvendus Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rejuvendus Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Rejuvendus Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Rejuvendus Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity Neera Sharma was appointed as a Director was appointed as a Director on 20 Jan 2010 & has been associated with this company since 15 years 11 months . was completed.
Anupam Gaur was appointed as a Director was appointed as a Director on 08 Nov 2006 & has been associated with this company since 19 years 1 month . was recorded as a recent event.
The activity Vikas Shri Prakash was appointed as a Director was appointed as a Director on 08 Nov 2006 & has been associated with this company since 19 years 1 month . was completed.
Rejuvendus Clinical Research Private Limited was registered on 08 Nov 2006 with Roc Delhi & aged 19 years 1 month as per MCA records. was recorded as a recent event.
The CIN of Rejuvendus Clinical Research Private Limited is U24232DL2006PTC155302.
Rejuvendus Clinical Research Private Limited is headquartered at 31/55, 1St Floor Gali No. - 1, Kapashera, Delhi, 110037.
Rejuvendus Clinical Research Private Limited was incorporated on 08 November 2006.
The current directors of Rejuvendus Clinical Research Private Limited are
The primary industry of Rejuvendus Clinical Research Private Limited is Hospital And Medical Care.
Rejuvendus Clinical Research Private Limited is unlisted.
The authorized capital of Rejuvendus Clinical Research Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Rejuvendus Clinical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX